- Learning Objective 1: Understand that disease-modifying therapies can be applied to the treatment or prevention of type 1 diabetes.
- Learning Objective 2: Understand that type 1 diabetes can be accurately identified in the presymptomatic phase.
- Learning Objective 3: Understand that measures of beta cell dysfunction can inform type 1 diabetes prediction and interventions.
10/06/2022 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Emily Sims, MD